139 related articles for article (PubMed ID: 38394627)
1. Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows.
Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG
J Appl Clin Med Phys; 2024 Apr; 25(4):e14253. PubMed ID: 38394627
[TBL] [Abstract][Full Text] [Related]
2. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
[TBL] [Abstract][Full Text] [Related]
3. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
4. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
9. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
[TBL] [Abstract][Full Text] [Related]
11. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment.
Christiansen RL; Dysager L; Hansen CR; Jensen HR; Schytte T; Nyborg CJ; Bertelsen AS; Agergaard SN; Mahmood F; Hansen S; Hansen O; Brink C; Bernchou U
Radiother Oncol; 2022 Feb; 167():165-171. PubMed ID: 34923034
[TBL] [Abstract][Full Text] [Related]
12. A new workflow of the on-line 1.5-T MR-guided adaptive radiation therapy.
Uno T; Tsuneda M; Abe K; Fujita Y; Harada R; Saito M; Kanazawa A; Kodate A; Abe Y; Ikeda Y; Nemoto MW; Yokota H
Jpn J Radiol; 2023 Nov; 41(11):1316-1322. PubMed ID: 37354344
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study.
Ingle M; White I; Chick J; Stankiewicz H; Mitchell A; Barnes H; Herbert T; Nill S; Oelfke U; Huddart R; Ng-Cheng-Hin B; Hafeez S; Lalondrelle S; Dunlop A; Bhide S
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e135-e142. PubMed ID: 36336579
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
[TBL] [Abstract][Full Text] [Related]
17. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test.
Han EY; Wang H; Briere TM; Yeboa DN; Boursianis T; Kalaitzakis G; Pappas E; Castillo P; Yang J
J Appl Clin Med Phys; 2022 Mar; 23(3):e13518. PubMed ID: 34994101
[TBL] [Abstract][Full Text] [Related]
18. First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac.
Wegener D; Thome A; Paulsen F; Gani C; Boldt J; Butzer S; Thorwarth D; Moennich D; Nachbar M; Müller AC; Zips D; Boeke S
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012885
[TBL] [Abstract][Full Text] [Related]
19. The impact of gadolinium-based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac.
Hales RB; Chuter R; McWilliam A; Salah A; Dubec M; Freear L; McDaid L; Aznar M; van Herk M; McPartlin A; Eccles CL
Med Phys; 2022 Jan; 49(1):510-520. PubMed ID: 34741308
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric analysis of MR-LINAC treatment plans for salvage spine SBRT re-irradiation.
Han EY; Yeboa DN; Briere TM; Yang J; Wang H
J Appl Clin Med Phys; 2022 Oct; 23(10):e13752. PubMed ID: 36004700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
